Autres langues Scancell Holdings plc

Actions

SCLP

GB00B63D3314

Recherche biotechnologique et médicale

Marché Fermé - 17:35:29 11/09/2026 Varia. 5j. Varia. 1 janv.
10,15 GBX +0,50% Graphique intraday de Scancell Holdings plc +6,17% +2,53%

Autres langues

03/09 Scancell to Present at the H.C. Wainwright 28th Annual Global Investment Conference
19/08 EARNINGS AND TRADING: Cooks sales up; Amcomri profit rises, debt falls
19/08 UK Regulator Allows Scancell Holdings to Launch Late-stage Trial for Advanced Melanoma Therapy
27/07 Scancell Raises GBP3 Million via Oversubscribed Share Placing
24/07 Scancell raises placing; Tavistock settles with Titan
23/07 Scancell Holdings plc agreed to acquire Neuphoria Therapeutics Inc. for $35 million.
23/07 Scancell agrees to buy Neuphoria, combined firm set to list on Nasdaq
23/07 Stocks down as eurozone rate call nears
23/07 WINNERS & LOSERS: capAI gains exclusive licence for Ageotype platform
23/07 Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing
23/07 Scancell Holdings Plans $12 Million Share Placing
23/07 Scancell, Neuphoria Therapeutics Agree All-share Merger
29/06 Neuphoria responds to the announcement made by London-listed Scancell Holdings plc
28/06 Scancell Is in Talks over Possible Equity and Debt Financing
26/06 Neuphoria Confirms Business Combination Talks With Scancell
26/06 Neuphoria Responds to the Announcement Made by London-Listed Scancell Holdings plc
26/06 Scancell Confirms Advanced Talks for Potential Acquisition of Nasdaq-listed Neuphoria Therapeutics
26/06 Scancell confirms advanced talks on takeover of Neuphoria; eyes Nasdaq
26/06 Scancell confirms advanced talks on takeover of Neuphoria; eyes Nasdaq
26/06 Scancell Confirms Advanced Talks over Reverse Merger with Neuphoria
11/06 WINNERS & LOSERS: Aeorema wins climate event deal; RWS cuts dividend
20/05 WINNERS & LOSERS: Indonesia curbs hit MP Evans; S&U rises
28/04 Conduit CFO Whelan to step down in September
28/04 US FDA Grants Scancell's Melanoma Drug Candidate Fast Track Designation
28/04 Scancell Holdings receives FDA fast track designation for iSCIB1+ in advanced melanoma
Aucun résultat pour cette recherche
-40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT